TD Asset Management
KRON

TD Asset Management’s Kronos Bio KRON Stock Holding History

TD Asset Management’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-15,219
Closed -$24.7K – 1448
2022
Q4 		$24.7K Hold
15,219
– – ﹤0.01% 1425
2022
Q3 		$51K Hold
15,219
– – ﹤0.01% 1439
2022
Q2 		$55K Hold
15,219
– – ﹤0.01% 1427
2022
Q1 		$110K Sell
15,219
-39,554
-72% -$337K ﹤0.01% 1450
2021
Q4 		$744K Hold
54,773
– – ﹤0.01% 1331
2021
Q3 		$1.15M Hold
54,773
– – ﹤0.01% 1218
2021
Q2 		$1.12M Buy
54,773
+21,936
+67% +$555K ﹤0.01% 1236
2021
Q1 		$961K Buy
32,837
+3,225
+11% +$94.5K ﹤0.01% 1269
2020
Q4 		$885K Buy
+29,612
New +$929K ﹤0.01% 1207

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

TD Asset Management's KRON Position: Q1 2023 in Review

TD Asset Management sold out of Kronos Bio (KRON) in Q1 2023, closing a stake of 15,219 shares — an estimated $24.7K sold.

TD Asset Management first reported a position in KRON in Q4 2020 and held it in 9 quarters. The position peaked at $1.15M in Q3 2021. 87 funds tracked by Wall St. Rank hold KRON as of Q1 2023.

  • TD Asset Management reported no remaining Kronos Bio position as of Q1 2023 after selling out during the quarter.
  • TD Asset Management sold 15,219 Kronos Bio shares in Q1 2023, an estimated $24.7K.
  • TD Asset Management first reported a position in Kronos Bio in Q4 2020 and held it in 9 quarters.
  • TD Asset Management's Kronos Bio position peaked at $1.15M in Q3 2021.
  • 87 funds tracked by Wall St. Rank held Kronos Bio as of Q1 2023.

Based on TD Asset Management's 13F filing for Q1 2023, filed 10 May 2023.